Personalized Neoantigen Vaccine with Durvalumab for Extensive Stage Small Cell Lung Cancer | Clinical Trial

Personalized Neoantigen Vaccine with Durvalumab for Extensive Stage Small Cell Lung Cancer | Clinical Trial | Right2Hope